Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Wuhan Easy Diagnosis Biomedicine Co Ltd
Wuhan Easy Diagnosis Biomedicine Co Ltd
Common Shares Outstanding
Wuhan Easy Diagnosis Biomedicine Co Ltd
Common Shares Outstanding Peer Comparison
300760
688271
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
Common Shares Outstanding
¥231.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Common Shares Outstanding
¥66.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Common Shares Outstanding
¥996.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Common Shares Outstanding
¥1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Common Shares Outstanding
¥1.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Common Shares Outstanding
¥819.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
231.2m
CNY
Based on the financial report for Mar 31, 2024, Wuhan Easy Diagnosis Biomedicine Co Ltd's Common Shares Outstanding amounts to 231.2m CNY.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
28%
Over the last year, the Common Shares Outstanding growth was 2%. The average annual Common Shares Outstanding growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been 51% over the past three years , 28% over the past five years .
You don't have any saved screeners yet
